Calcium  	Calcium  	 NNP	B-NP
and  	and  	 CC	O
phosphate  	phosphate  	 JJ	B-NP
changes  	changes  	 NNS	I-NP
after  	after  	 IN	O
renal  	renal  	 JJ	B-NP
transplantation  	transplantation  	 NN	I-NP
Hypercalcemia  	Hypercalcemia  	 NNP	I-NP
and  	and  	 CC	O
hypophosphatemia  	hypophosphatemia  	 NNS	B-NP
are  	are  	 VBP	O
frequently  	frequently  	 RB	O
observed  	observed  	 VBN	O
in  	in  	 IN	O
recipients  	recipients  	 NNS	O
of  	of  	 IN	O
a  	a  	 DT	O
kidney  	kidney  	 NN	B-NP
transplant  	transplant  	 NN	I-NP
( 	( 	 -LRB-	O
KTx 	KTx 	 NNP	B-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
Hypercalcemia  	Hypercalcemia  	 NNP	B-NP
has  	has  	 VBZ	O
been  	been  	 VBN	O
reported  	reported  	 VBN	O
in  	in  	 IN	O
up  	up  	 RB	O
to  	to  	 TO	O
66 	66 	 CD	O
%  	%  	 NN	O
of  	of  	 IN	O
KTx  	KTx  	 JJ	B-NP
patients 	patients 	 NNS	I-NP
.  	.  	 .	O
Many  	Many  	 JJ	O
factors  	factors  	 NNS	O
have  	have  	 VBP	O
been  	been  	 VBN	O
suggested  	suggested  	 VBN	O
as  	as  	 IN	O
the  	the  	 DT	O
putative  	putative  	 JJ	B-NP
causal  	causal  	 JJ	I-NP
factors 	factors 	 NNS	I-NP
;  	;  	 :	O
however 	however 	 RB	O
,  	,  	 ,	O
the  	the  	 DT	O
persistence  	persistence  	 NN	O
of  	of  	 IN	O
moderate-severe  	moderate-severe  	 JJ	B-NP
secondary  	secondary  	 JJ	I-NP
hyperparathyroidism 	hyperparathyroidism 	 NN	I-NP
,  	,  	 ,	O
associated  	associated  	 VBN	O
with  	with  	 IN	O
a  	a  	 DT	O
change  	change  	 NN	O
in  	in  	 IN	O
the  	the  	 DT	O
set-point  	set-point  	 JJ	B-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
Ca-controlled  	Ca-controlled  	 JJ	I-NP
parathyroid  	parathyroid  	 JJ	I-NP
hormone  	hormone  	 NN	I-NP
( 	( 	 -LRB-	O
PTH 	PTH 	 NNP	B-NP
)  	)  	 -RRB-	O
secretion 	secretion 	 NN	B-NP
,  	,  	 ,	O
is  	is  	 VBZ	O
considered  	considered  	 VBN	O
to  	to  	 TO	O
play  	play  	 VB	O
a  	a  	 DT	O
prominent  	prominent  	 JJ	O
role 	role 	 NN	O
.  	.  	 .	O
Hypercalcemia  	Hypercalcemia  	 NNP	B-NP
can  	can  	 MD	O
negatively  	negatively  	 VB	O
impact  	impact  	 NN	O
on  	on  	 IN	O
both  	both  	 PDT	O
the  	the  	 DT	O
graft  	graft  	 NN	O
and  	and  	 CC	O
patient  	patient  	 JJ	O
outcome 	outcome 	 NN	O
,  	,  	 ,	O
increasing  	increasing  	 VBG	O
the  	the  	 DT	O
incidence  	incidence  	 NN	O
of  	of  	 IN	O
nephrocalcinosis 	nephrocalcinosis 	 NN	B-NP
,  	,  	 ,	O
which  	which  	 WDT	O
can  	can  	 MD	O
induce  	induce  	 VB	O
a  	a  	 DT	O
worse  	worse  	 JJR	B-NP
graft  	graft  	 JJ	I-NP
outcome 	outcome 	 NN	I-NP
,  	,  	 ,	O
inducing  	inducing  	 VBG	O
vascular  	vascular  	 JJ	B-NP
calcifications 	calcifications 	 NN	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
increasing  	increasing  	 VBG	O
the  	the  	 DT	O
incidence  	incidence  	 NN	O
of  	of  	 IN	O
pancreatitis 	pancreatitis 	 NN	B-NP
.  	.  	 .	O
In  	In  	 IN	O
addition 	addition 	 NN	B-NP
,  	,  	 ,	O
severe  	severe  	 JJ	O
hypercalcemia  	hypercalcemia  	 NN	B-NP
after  	after  	 IN	O
KTx  	KTx  	 JJ	O
often  	often  	 RB	O
requires  	requires  	 VBZ	O
parathyroidectomy 	parathyroidectomy 	 VBN	O
,  	,  	 ,	O
which  	which  	 WDT	O
is  	is  	 VBZ	O
not  	not  	 RB	O
universally  	universally  	 RB	O
considered  	considered  	 VBN	O
a  	a  	 DT	O
safe  	safe  	 JJ	O
medical  	medical  	 JJ	B-NP
solution  	solution  	 NN	I-NP
in  	in  	 IN	O
this  	this  	 DT	O
clinical  	clinical  	 JJ	B-NP
setting 	setting 	 NN	I-NP
.  	.  	 .	O
After  	After  	 IN	O
KTx 	KTx 	 NNP	B-NP
,  	,  	 ,	O
phosphate  	phosphate  	 JJ	B-NP
levels  	levels  	 NNS	I-NP
often  	often  	 RB	O
fall  	fall  	 VB	O
below  	below  	 IN	O
the  	the  	 DT	O
normal  	normal  	 JJ	B-NP
range 	range 	 NN	I-NP
,  	,  	 ,	O
with  	with  	 IN	O
hypophosphatemia  	hypophosphatemia  	 NNS	B-NP
being  	being  	 VBG	O
observed  	observed  	 VBN	O
in  	in  	 IN	O
up  	up  	 RB	O
to  	to  	 TO	O
40 	40 	 CD	O
%  	%  	 NN	O
of  	of  	 IN	O
patients 	patients 	 NNS	O
.  	.  	 .	O
The  	The  	 DT	O
putative  	putative  	 JJ	B-NP
causal  	causal  	 JJ	I-NP
factors  	factors  	 NNS	I-NP
for  	for  	 IN	O
this  	this  	 DT	O
metabolic  	metabolic  	 JJ	B-NP
alteration  	alteration  	 NNS	I-NP
are  	are  	 VBP	O
persistent  	persistent  	 JJ	O
hyperparathyroidism 	hyperparathyroidism 	 NN	B-NP
,  	,  	 ,	O
increased  	increased  	 VBD	B-NP
levels  	levels  	 NNS	I-NP
of  	of  	 IN	I-NP
FGF-23 	FGF-23 	 NNP	I-NP
,  	,  	 ,	O
tubular  	tubular  	 JJ	B-NP
damage  	damage  	 NN	I-NP
secondary  	secondary  	 JJ	O
to  	to  	 TO	O
the  	the  	 DT	O
immunological  	immunological  	 JJ	B-NP
effects 	effects 	 NNS	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
toxic  	toxic  	 JJ	B-NP
and  	and  	 CC	O
vascular  	vascular  	 JJ	B-NP
effectors 	effectors 	 NN	I-NP
.  	.  	 .	O
Hypophosphatemia  	Hypophosphatemia  	 NNP	B-NP
can  	can  	 MD	O
negatively  	negatively  	 VB	O
impact  	impact  	 NN	O
on  	on  	 IN	O
either  	either  	 DT	O
skeletal  	skeletal  	 NN	B-NP
or  	or  	 CC	O
muscular  	muscular  	 JJ	B-NP
systems 	systems 	 NNS	I-NP
,  	,  	 ,	O
contributing  	contributing  	 VBG	O
to  	to  	 TO	O
the  	the  	 DT	O
increased  	increased  	 JJ	O
incidence  	incidence  	 NN	O
of  	of  	 IN	O
bone  	bone  	 NN	O
fractures  	fractures  	 NN	O
in  	in  	 IN	O
KTx  	KTx  	 JJ	B-NP
patients 	patients 	 NNS	I-NP
.  	.  	 .	O
The  	The  	 DT	O
current  	current  	 JJ	O
therapeutic  	therapeutic  	 JJ	B-NP
options  	options  	 NNS	I-NP
should  	should  	 MD	O
take  	take  	 VB	O
into  	into  	 IN	O
account  	account  	 NN	O
an  	an  	 DT	O
accurate  	accurate  	 JJ	O
pretransplant  	pretransplant  	 JJ	B-NP
treatment  	treatment  	 NN	I-NP
and  	and  	 CC	O
screening  	screening  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
waiting-list  	waiting-list  	 JJ	O
patient  	patient  	 NN	O
and  	and  	 CC	O
should  	should  	 MD	O
also  	also  	 RB	O
evaluate  	evaluate  	 VB	O
the  	the  	 DT	O
efficacy  	efficacy  	 NN	O
and  	and  	 CC	O
safety  	safety  	 NN	O
profile  	profile  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
new  	new  	 JJ	O
pharmacological  	pharmacological  	 JJ	B-NP
tools  	tools  	 NNS	I-NP
( 	( 	 -LRB-	O
calcimimetics 	calcimimetics 	 LS	B-NP
)  	)  	 -RRB-	O
in  	in  	 IN	O
comparison  	comparison  	 NN	O
with  	with  	 IN	O
the  	the  	 DT	O
classical  	classical  	 JJ	B-NP
surgical  	surgical  	 JJ	I-NP
approach  	approach  	 NN	I-NP
( 	( 	 -LRB-	O
parathyroidectomy 	parathyroidectomy 	 LS	B-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
